For Health Technology Assessment is intended a “multi-disciplinary field of policy analysis that studies the medical, social, ethical, and economic implications of development, diffusion, and use of health technology” (INAHTA, 2013). It practically consists in the evaluation of new technologies, in terms of effects and impacts on the healthcare system, with the purpose of informing the policy makers about their cost-effectiveness and safety and value for the patients.
Health Technology Assessment has a broad meaning, covering medical, social, economic and ethical issues. Diagnostic and treatment methods, medical equipment, pharmaceuticals, rehabilitation and prevention methods, but also organisational and support systems used to deliver healthcare are examples of Health Technologies subject to assessment.
In 2004, the European Commission and the Council of Ministers recognized HTA as a priority in Europe and, for this reason, encouraged the creation of a network on the topic achieving the following goals: to enhance the efficient use of HTA; to share knowledge about HTA in a sustainable way; to recognize and to promote good practices of HTA.
As a result, a call was launched by the European Commission in 2005 and 35 organisations lead by the Danish Centre for HTA (DACEHTA) in Copenhagen answered. In 2009 the European network for HTA became a stable and sustainable collaboration called EUnetHTA and from 2010 to 2012 many organisations and Member States took part of the first Joint Action on the topic. In 2012 the second Joint Action was launched and HOPE is part of it as stakeholder representing providers of healthcare services.
Joint Action 1 on Health Technology Assessment
Joint Action 2 on Health Technology Assessment
Joint Action 3 on Health Technology Assessment